IVA:NASDAQInventiva S.A. - American Depository Shares analysis
Data as of Sep 23, 2026 - not real-time
- Latest price
- $3.53
- Risk: high
- 9/10High risk
Summary
Inventiva S.A. is priced at $3.53 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 25.7%. RSI sits at 22.5, which reads as oversold, and MACD momentum is bearish. Watch $3.52 as support and $5.10 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 321.4% above the current price. Revenue is contracting at 89.9%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 37.3%, a beta of 1.28 and a maximum drawdown of 52.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 321.4% above the current price. Revenue is contracting at 89.9%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 37.3%, a beta of 1.28 and a maximum drawdown of 52.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top market events
- Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohort and 410 patients...
- News zur INVENTIVA SA ADR AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ Stifel reiterates Buy on Inventiva stock, $15...
- Phase 1 and Phase 2 clinical data showed lanifibranor improves metabolic profile and cardiovascular risk factors in...
Market outlook
Short term
< 1 yearNeutral
Model confidence3/103 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- RSI at 22.5 signals oversold conditions
- Trading below the 200-day average of 5.06
Medium term
1–3 yearsNeutral
Model confidence2/102 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- RSI at 22.5 signals oversold conditions
- Trading below the 200-day average of 5.06
Long term
> 3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Analyst targets imply +321.4% versus the current price
- Revenue contracting at -89.9%
- Negative free cash flow
Key metrics
Financial health
Revenue Growth-89.90%
P/E Ratio-4.4
ROA-45.08%
P/B Ratio-20.6
Op. Cash Flow$-104884000
Free Cash Flow$-200711632
Industry P/E30.5
Technical analysis
TrendBearish
RSI22.5
Support$3.52
Resistance$5.10
MA 20$4.33
MA 50$4.48
MA 200$5.06
MACDBearish
VolumeIncreasing
Fear & Greed Index95.93
Valuation
Target Price$14.87
Upside/Downside321.36%
GradeFair
TypeBlend
Risk assessment
Beta1.28
Volatility37.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.